{
    "organizations": [],
    "uuid": "f114c4868af7f122bd170dfbf570ab4037e60e55",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-avadel-pharmaceuticals-announces-p/brief-avadel-pharmaceuticals-announces-proposed-exchangeable-senior-notes-offering-idUSASB0C5J4",
    "ord_in_thread": 0,
    "title": "Avadel Pharmaceuticals Announces Proposed Exchangeable Senior Notes Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Avadel Pharmaceuticals Plc:\n* AVADEL PHARMACEUTICALS ANNOUNCES PROPOSED EXCHANGEABLE SENIOR NOTES OFFERING\n* AVADEL PHARMACEUTICALS PLC - UNIT INTENDS TO OFFER $125 MILLION PRINCIPAL AMOUNT OF EXCHANGEABLE SENIOR NOTES DUE 2023 IN A PRIVATE OFFERINGâ€‹ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T05:39:00.000+02:00",
    "crawled": "2018-02-14T12:21:10.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "avadel",
        "pharmaceutical",
        "plc",
        "avadel",
        "pharmaceutical",
        "announces",
        "proposed",
        "exchangeable",
        "senior",
        "note",
        "offering",
        "avadel",
        "pharmaceutical",
        "plc",
        "unit",
        "intends",
        "offer",
        "million",
        "principal",
        "amount",
        "exchangeable",
        "senior",
        "note",
        "due",
        "private",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}